Detailed understanding of the mechanism through which estrogen and tamoxifen affect MTO1 and MRPL41 transcription is expected to provide new insights into breast cancer progression and suggest new strategies for delaying or reversing this process. Here, MRPL41 is linked to breast carcinoma.